389 related articles for article (PubMed ID: 29887138)
1. The cellular and pathologic prion protein.
Gill AC; Castle AR
Handb Clin Neurol; 2018; 153():21-44. PubMed ID: 29887138
[TBL] [Abstract][Full Text] [Related]
2.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
3. Differential Accumulation of Misfolded Prion Strains in Natural Hosts of Prion Diseases.
Lambert ZJ; Greenlee JJ; Cassmann ED; West Greenlee MH
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960722
[TBL] [Abstract][Full Text] [Related]
4. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
5. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
6. Structural Consequences of Copper Binding to the Prion Protein.
Salzano G; Giachin G; Legname G
Cells; 2019 Jul; 8(8):. PubMed ID: 31349611
[TBL] [Abstract][Full Text] [Related]
7. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
8. Biology and Genetics of PrP Prion Strains.
Ghaemmaghami S
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 27920025
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
10. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.
Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y
FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.
Khadka A; Spiers JG; Cheng L; Hill AF
Cell Tissue Res; 2023 Apr; 392(1):247-267. PubMed ID: 35394216
[TBL] [Abstract][Full Text] [Related]
12. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
13. Role of proteomics in understanding prion infection.
Campisi E; Cardone F; Graziano S; Galeno R; Pocchiari M
Expert Rev Proteomics; 2012 Dec; 9(6):649-66. PubMed ID: 23256675
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
15. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
Eraña H; Venegas V; Moreno J; Castilla J
Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
[TBL] [Abstract][Full Text] [Related]
16. α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein.
Kobayashi A; Hirata T; Nishikaze T; Ninomiya A; Maki Y; Takada Y; Kitamoto T; Kinoshita T
J Biol Chem; 2020 May; 295(22):7789-7798. PubMed ID: 32321762
[TBL] [Abstract][Full Text] [Related]
17. Prion-Like Characteristics of Polyglutamine-Containing Proteins.
Pearce MMP; Kopito RR
Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 28096245
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.
Hirsch TZ; Martin-Lannerée S; Reine F; Hernandez-Rapp J; Herzog L; Dron M; Privat N; Passet B; Halliez S; Villa-Diaz A; Lacroux C; Klein V; Haïk S; Andréoletti O; Torres JM; Vilotte JL; Béringue V; Mouillet-Richard S
Mol Neurobiol; 2019 Mar; 56(3):2159-2173. PubMed ID: 29998397
[TBL] [Abstract][Full Text] [Related]
19. Structural Biology of PrP Prions.
Stubbs G; Stöhr J
Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28003279
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
